ArticleBiomarker research2015

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.

Andrea M Marquard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.